Premium Healthcare Group
EEGX:EGS72XL1C0140.09
EGP
0.00
(0.00%)
ISIN
EGS72XL1C014
Return %
Stock
S&P 500
1Y
-47.09
13.14
3Y
- -
80.78
5Y
- -
67.74
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Cairo Egypt
- Similar Companies
- Business
- Premium Healthcare Group is an Egypt-based healthcare holding company specializing in clinical laboratory testing, medical diagnostics, healthcare management, and medical logistics services. Founded in 2014 and headquartered in Cairo, Egypt, the company operates an extensive network of diagnostic laboratories and medical facilities serving individual patients, corporate clients, healthcare practitioners, and health insurance providers across Egypt, with regional development initiatives extending into Middle East and North Africa markets including Saudi Arabia, Jordan, and the United Arab Emirates. The company delivers a comprehensive portfolio of medical diagnostic and healthcare solutions organized across specialized operational brands: routine and advanced diagnostic pathology services including hematology, clinical chemistry, immunology, microbiology, and parasitology (City Labs and Almostakbal Labs); advanced molecular diagnostics, genetic testing, and specialized biomarker analysis (Ezzlab); routine, specialized, and referral clinical testing (Hesab Labs and Town Lab); specialized diagnostic oncology, endocrinology, and comprehensive hormone profiling (Cairo Clinical Labs); outpatient care and polyclinic healthcare services (El Eyada Company); and integrated medical logistics, laboratory supply chain management, and diagnostic facility administration services (Khadamat Medical). In recent strategic developments, the company executed a comprehensive corporate transformation, officially rebranding from City Lab to Premium Healthcare Group following its listing on the Egyptian Exchange under ticker symbol PHGC (ISIN: EGS72XL1C014). As part of this transition into an integrated regional healthcare platform, the group completed an aggressive multi-brand acquisition and consolidation strategy, securing controlling interests in multiple diagnostic chains and clinical entities including Ezz Laboratories, Hassab Labs, Cairo Clinical Lab, Almostakbal Labs, Town Lab, El Eyada, and Khadamat. To fund this expansion and optimize its capital structure, the company structured a major capital increase utilizing a debt-to-equity conversion framework to settle acquisition liabilities, alongside establishing strategic partnerships to scale its specialized diagnostic testing network across the broader MENA region.